| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.83B | +76.2% |
| Cost of Revenue | $268.2M | +91.3% |
| R&D Expense | $1.00B | +13.7% |
| SG&A Expense | $795.6M | +3.2% |
| Operating Income | -$282.2M | +64.1% |
| Interest Expense | $121.2M | -22.3% |
| Pre-tax Income | -$433.5M | +61.5% |
| Income Tax | $6.7M | +61.5% |
| Net Income | -$440.2M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $812.7M | -6.2% |
| Accounts Receivable | $327.8M | +37.7% |
| Inventory | $89.1M | -30.9% |
| Current Assets | $2.98B | +10.8% |
| Total Assets | $3.83B | +8.0% |
| Current Liabilities | $967.8M | +26.0% |
| Total Liabilities | $4.05B | +9.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $104.2M | +119.2% |
| Capital Expenditures | $62.2M | -13.7% |
| Investing Cash Flow | -$336.4M | -298.6% |
| Financing Cash Flow | $172.1M | -59.6% |
| Free Cash Flow | $41.9M | +106.8% |
| +61.1% |
| EPS (Basic) | -$3.52 | +62.2% |
| EPS (Diluted) | -$3.52 | +62.2% |
| Stockholders' Equity |
| -$220.6M |
| -39.5% |